NCT06613139View on ClinicalTrials.gov

Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 6, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

October 24, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

YHP2305

Test drug: YHP2305 Comparator: YHR2404

DRUG

YHR2404

Test drug: YHP2305 comparator: YHR2404

Trial Locations (1)

07590

Bumin Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT06613139 - Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers | Biotech Hunter | Biotech Hunter